Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024 09:30 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.
Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
October 28, 2024 02:00 ET
|
Royal Philips
October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by...
Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
August 16, 2024 09:00 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA
Philips to repurchase shares for up to EUR 125 million to cover long-term incentive plans
August 05, 2024 06:00 ET
|
Royal Philips
August 5, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase shares for an amount of up to EUR 125 million to cover certain of its...
Philips delivers strong order intake growth in the second quarter, margin improvement and sales growth; reiterates full-year outlook
July 29, 2024 01:00 ET
|
Royal Philips
July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2%Comparable order intake increased by 9%Income from operations EUR 816...
Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6 millions de dollars au troisième trimestre 2023,...
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity
Philips completes cancellation of 4.4 million shares
June 19, 2024 07:00 ET
|
Royal Philips
June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were...
Philips announces exchange ratio for 2023 dividend
May 15, 2024 05:00 ET
|
Royal Philips
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684...
Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion
April 29, 2024 01:00 ET
|
Royal Philips
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion...